Skip to main content

RBM to Use $849K from NIGMS to Develop Dx for Neonatal Sepsis

NEW YORK (GenomeWeb News) - Rules Based Medicine has won an $849,000 fast-track grant from the National Institute for General Medical Sciences to develop a test through a collaboration with the University of New Mexico in Albuquerque that would diagnose neonatal sepsis.
The company said that it will perform all of the testing and statistical analysis on samples provided by the University of New Mexico’s Neonatal Intensive Care ward. Specifically, RBM will use its HumanMAP platform to characterize and validate a pattern of biomarkers that can detect early signs of infection in newborns.
“The ability to routinely monitor serum biomarkers for the earliest signs of infection could have a significant impact on the survival rates of the newborns most at risk,” said UNM Professor of Medicine Clifford Lyons.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.